Biohaven Pharma (BHVN) Misses Q1 EPS by 4c
Tweet
Share
E-mail
Get Alerts BHVN Hot Sheet
Join SI Premium – FREE
Biohaven Pharma (NYSE: BHVN) reported Q1 EPS of ($0.88), $0.04 worse than the analyst estimate of ($0.84).
For earnings history and earnings-related data on Biohaven Pharma (BHVN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tradeweb Markets (TW) PT Lowered to $151 at Raymond James
- Adia Nutrition seeks FINRA approval for name change to Adia Med
- Unum Group (UNM) PT Raised to $94 at UBS on Second LTC Deal
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
